Showing results (11-20 of 19) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Therapeutic Advances in Neurological Disorders|May 26, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapiesAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.Journal of Neuroimmunology|October 16, 2021
Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional studyAnat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|April 15, 2021
COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021Anat Achiron, Mark Dolev, Shay Menascu, et al.Journal of the Neurological Sciences|January 29, 2022
COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster doseSapir Dreyer-Alster, Shay Menascu, Mathilda Mandel, et al.Journal of Neurology, Neurosurgery, and Psychiatry|September 30, 2016
Highly active immunomodulatory therapy ameliorates accumulation of disability in moderately advanced and advanced multiple sclerosisNathaniel Lizak, Alessandra Lugaresi, Raed Alroughani, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|December 7, 2014
Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosisTomas Kalincik, Vilija Jokubaitis, Guillermo Izquierdo, et al.Annals of Neurology|October 7, 2014
Seasonal variation of relapse rate in multiple sclerosis is latitude dependentTim Spelman, Orla Gray, Maria Trojano, et al.Brain : a Journal of Neurology|October 21, 2017
Towards personalized therapy for multiple sclerosis: prediction of individual treatment responseTomas Kalincik, Ali Manouchehrinia, Lukas Sobisek, et al.Brain : a Journal of Neurology|October 22, 2013
Sex as a determinant of relapse incidence and progressive course of multiple sclerosisTomas Kalincik, Vino Vivek, Vilija Jokubaitis, et al.Pageof 2